Immunofluorescent staining of metastatic carcinoma cells in serous fluid with carcinoembryonic antibody, epithelial membrane antibody, AUA‐1 and BER‐EP4

Using an indirect immunofluorescence technique, we assessed the accuracy and clinical usefulness of a panel of monoclonal and polyclonal antibodies. the panel consisted of carcinoembryonic antibody (CEA) and epithelial membrane antibody (EMA), AUA‐1, and Ber‐EP4 conjugated with fluorescein isothiocyanate. Twenty‐six specimens from pleural, peritoneal or pericardial effusions known to contain carcinoma cells (adenocarcinoma or large cell anaplastic carcinoma) and 16 specimens without carcinoma were first examined. the sensitivity and specificity for each of the antibodies were as follows: CEA, 71% and 75%; EMA, 96% and 81%; AUA‐1, 80% and 100%; and Ber‐EP4, 85% and 100%, respectively. the panel of antibodies was then applied to a group of 14 ‘problematic’ fluids. These had been identified as causing dilemmas in interpretation, either because the cells in the fluids were of equivocal appearance on light microscopy, or the cytological diagnosis was different from that expected in the light of the clinical condition of the patient. Insufficient cellular material was present in one specimen. In five (39%) of the cases the immunochemical staining supported the light microscopic diagnosis. In four (30%) cases, however, the results indicated that the original light microscopic report was incorrect. Two of these were examples of large cell carcinoma of the lung, in which false negative reports had been issued on pleural fluids. the other two were cases of benign ovarian tumours in which a false positive report had been issued. the immunostaining also clarified the final diagnosis in the three patients (23%) on whom ‘suspicious’ cytological reports had previously been issued. the remaining case, fluid from a patient with a high grade mixed Mullerian tumour of the ovary, was unresolved. We conclude that immunofluorescent staining by AUA‐1, EMA and Ber‐EP4 is an aid in the cytological interpretation of serous fluids. CEA is much less helpful.

[1]  J. Silverman,et al.  Immunocytochemical panel for the identification of malignant cells in serous effusions. , 1991, American journal of clinical pathology.

[2]  K. Berghäuser,et al.  Distinction of mesothelioma from carcinoma in pleural effusions. An immunocytochemical study on routinely processed cytoblock preparations. , 1991, Pathology, research and practice.

[3]  C. Vincent,et al.  Immunophenotyping of Mesothelial Cells and Carcinoma Cells With Monoclonal Antibodies to Cytokeratins, Vimentin, Cea and Ema Improves the Cytodiagnosis of Serous Effusions , 1991, Cytopathology : official journal of the British Society for Clinical Cytology.

[4]  H. Battifora,et al.  Immunocytochemical profile of benign and carcinomatous effusions. A practical approach to difficult diagnosis. , 1990, American journal of clinical pathology.

[5]  M. Pastormerlo Immunoperoxidase staining of malignant cells in pleural effusions. , 1990, Pathologica.

[6]  C. Cohen,et al.  Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry. , 1990, Acta cytologica.

[7]  P. Carder,et al.  Monoclonal antibodies in the cytodiagnosis of serous effusions , 1990, Cytopathology : official journal of the British Society for Clinical Cytology.

[8]  H. Stein,et al.  Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. , 1990, Journal of clinical pathology.

[9]  A. Thor,et al.  The application of monoclonal antibodies in the cytologic evaluation of tumors. , 1990, Clinics in laboratory medicine.

[10]  Abraham Fuks,et al.  Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule , 1989, Cell.

[11]  R. Osamura Applications of immunocytochemistry to diagnostic cytopathology , 1989, Diagnostic cytopathology.

[12]  F. Grunert,et al.  Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells. , 1988, Acta cytologica.

[13]  C. Bedrossian,et al.  Value of immunocytochemistry in the study of malignant effusions , 1987, Diagnostic cytopathology.

[14]  P. Möller,et al.  Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. , 1987, Cancer research.

[15]  S. Hajdu,et al.  The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. , 1987, Acta cytologica.

[16]  J. Said,et al.  Epithelial membrane antigen in the cytodiagnosis of effusions and aspirates: Immunocytochemical and ultrastructural localization in benign and malignant cells , 1987, Diagnostic cytopathology.

[17]  W. Bodmer,et al.  Characterization and chromosomal assignment of a human cell surface antigen defined by the monoclonal antibody AUAI , 1986, International journal of cancer.

[18]  P. Betta,et al.  Carcinoembryonic antigen in pleural effusions. Diagnostic value in malignant mesothelioma , 1984, Cancer.

[19]  J. Said,et al.  Keratin and carcinoembryonic antigen in exfoliated mesothelial and malignant cells: an immunoperoxidase study. , 1983, American journal of clinical pathology.

[20]  A. Ghosh,et al.  Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease. , 1983, Journal of clinical pathology.

[21]  E J Holborow,et al.  Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy. , 1982, Journal of immunological methods.

[22]  W. Bodmer,et al.  USE OF TWO EPITHELIUM-SPECIFIC MONOCLONAL ANTIBODIES FOR DIAGNOSIS OF MALIGNANCY IN SEROUS EFFUSIONS , 1982, The Lancet.

[23]  D. Dearnaley,et al.  Epithelial Membrane Antigen. Its use in the cytodiagnosis of malignancy in serous effusions. , 1982, American journal of clinical pathology.

[24]  H. Stein,et al.  Ber-EP 4 : new monoclonal antibody which distinguishes epithelia from mesothelia , 2022 .